Kerberos Proximal Solutions Inc.
This article was originally published in Start Up
Executive Summary
Kerberos' KEPTembolic protection catheter system uses an alternating rinsing and aspiration action -- "Rinspiration" -- to capture and retrieve more embolic mass, including small particles.
You may also be interested in...
FoxHollow Makes First Acquisition, Buys Kerberos
After much anticipation, atherectomy leader FoxHollow Technologies has finally joined the ranks of the acquirers, buying Kerberos Proximal Solutions, maker of the Rinspiration system, which is a catheter-based system that both rinses and aspirates vessels to remove blood clots and soft emboli. Both companies are currently focusing on treating peripheral vascular disease.
FoxHollow Makes First Acquisition, Buys Kerberos
After much anticipation, atherectomy leader FoxHollow Technologies has finally joined the ranks of the acquirers, buying Kerberos Proximal Solutions, maker of the Rinspiration system, which is a catheter-based system that both rinses and aspirates vessels to remove blood clots and soft emboli. Both companies are currently focusing on treating peripheral vascular disease.
Embolic Protection: Better Outcomes Not Enough
For 20 years, interventional cardiologists denied the need for embolic protection devices, considering embolic events to generally be the infrequent results of poor technique. Nevertheless, recent data has revealed embolization as a potentially serious and relatively common event during percutaneous coronary interventions. While embolic protection devices have been shown to dramatically reduce embolic complications, physician adoption is slow. Several companies are developing different approaches to protect against embolization, recognizing that better patient data alone isn't enough to convince interventionalists to employ these devices.